Nicholas Von Bergen, MD, Awarded Grant from Altathera Pharmaceuticals

Nicholas H. Von Bergen, MD
Nicholas Von Bergen, MD

Congratulations to Nicholas Von Bergen, MD, who was recently awarded $5,000 for his participation in the project, “Intravenous Sotalol in Pediatric and Congenital Patients: A Multi-Center Registry Study.” The purpose of this study, sponsored by Altathera Pharmaceuticals and the Pediatric & Congential Electrophysiology Society (PACES), is to evaluate the safety, efficacy, and dosing of IV sotalol in pediatric patients with tachyarrhythmias as well as adults with congenital heart disease.

Leave a Reply